Health
FDA authorizes marketing of new device designed to remove dead pancreatic tissue – FDA.gov
): FDA granted de novo for the EndoRotor System to resection (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis.
For Immediate Release:
December 23, 2020
Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.
This device has shown its potential to provide a minimally invasive way to remove harmful necrotic pancreatic tissue…
-
General21 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General7 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News22 hours agoWorker rushed to hospital after becoming trapped in machinery during horror workplace accident in Salisbury
-
General19 hours agoRobin Williams’s daughter begs fans to stop making AI content of her father